Why is Astec Lifescienc falling/rising?

As of 03-Sep, Astec Lifesciences Ltd is experiencing a decline in its stock price, currently at 852.35, reflecting a decrease of 1.9 points or 0.22%. The stock has been underperforming, having fallen for the last three consecutive days, resulting in a total decline of 3.06% during this period. In terms of broader performance, the stock has shown a significant downturn, with a year-to-date drop of 15.19% and a staggering 29.08% decrease over the past year. The company has faced operating losses and has reported negative results for the last five consecutive quarters, which has contributed to its weak long-term fundamental strength. Additionally, the stock's high Debt to EBITDA ratio and low Return on Equity indicate challenges in profitability and debt servicing, further impacting investor sentiment. In the broader market context, the stock's short-term performance is slightly better than the benchmark, with a 1-week return of -0.08% compared to the Sensex's -0.27%. However, the overall trend remains negative, especially when considering the stock's consistent underperformance against the benchmark over the last three years. The declining investor participation, evidenced by a 49.38% drop in delivery volume, suggests waning interest among traders, which could exacerbate the stock's downward trajectory. Despite touching an intraday high of Rs 887.2, the overall market sentiment and the company's financial struggles indicate a challenging environment for Astec Lifesciences Ltd.